Axys and Bristol-Myers end HCV partnership

AXPH and BMY ended their 1997 collaboration to develop inhibitors to the hepatitis C virus (HCV) protease. Separately, AXPH said its combinatorial chemistry subsidiary, Axys Advanced Technologies, wil...